TITAN PHARMACEUTICALS INC - COM NEW (TTNP)

CUSIP: 888314705

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COM NEW
Total 13F shares
37,686
Share change
+12,315
Total reported value
$158,276
Price per share
$4.00
Number of holders
20
Value change
+$51,725
Number of buys
4
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 888314705?
CUSIP 888314705 identifies TTNP - TITAN PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TITAN PHARMACEUTICALS INC - COM NEW (TTNP) as of Q2 2025

As of 30 Jun 2025, TITAN PHARMACEUTICALS INC - COM NEW (TTNP) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,686 shares. The largest 10 holders included CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Marex Group plc, UBS Group AG, CoreCap Advisors, LLC, BANK OF AMERICA CORP /DE/, GROUP ONE TRADING LLC, OSAIC HOLDINGS, INC., BlackRock, Inc., and MORGAN STANLEY. This page lists 20 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.